AbCellera Biologics (ABCL) PT Lowered to $38 at Berenberg
Tweet
Share
E-mailGet Alerts ABCL Hot Sheet
Price: $11.36 +0.71%
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 6 | New: 12
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 6 | New: 12
Join SI Premium – FREE
Berenberg analyst Gaurav Goparaju lowered the price target on AbCellera Biologics (NASDAQ: ABCL) to $38.00 (from $43.00) while maintaining a Buy rating.
You May Also Be Interested In
- Deutsche Bank Upgrades Azimut Holdings SpA (AZM:IM) (AZIHY) to Buy
- Credito Emiliano SpA (CE:IM) PT Raised to EUR20 at Deutsche Bank
- FinecoBank (FBK:IM) (FCBBF) PT Raised to EUR23.40 at Deutsche Bank
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
